PT3305770T - Processo para a produção de forma cristalina de enzalutamida - Google Patents

Processo para a produção de forma cristalina de enzalutamida

Info

Publication number
PT3305770T
PT3305770T PT168032480T PT16803248T PT3305770T PT 3305770 T PT3305770 T PT 3305770T PT 168032480 T PT168032480 T PT 168032480T PT 16803248 T PT16803248 T PT 16803248T PT 3305770 T PT3305770 T PT 3305770T
Authority
PT
Portugal
Prior art keywords
producing
crystal form
enzalutamide
enzalutamide crystal
producing enzalutamide
Prior art date
Application number
PT168032480T
Other languages
English (en)
Original Assignee
Astellas Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astellas Pharma Inc filed Critical Astellas Pharma Inc
Publication of PT3305770T publication Critical patent/PT3305770T/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/86Oxygen and sulfur atoms, e.g. thiohydantoin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/41641,3-Diazoles
    • A61K31/41661,3-Diazoles having oxo groups directly attached to the heterocyclic ring, e.g. phenytoin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C331/00Derivatives of thiocyanic acid or of isothiocyanic acid
    • C07C331/16Isothiocyanates
    • C07C331/28Isothiocyanates having isothiocyanate groups bound to carbon atoms of six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C30CRYSTAL GROWTH
    • C30BSINGLE-CRYSTAL GROWTH; UNIDIRECTIONAL SOLIDIFICATION OF EUTECTIC MATERIAL OR UNIDIRECTIONAL DEMIXING OF EUTECTOID MATERIAL; REFINING BY ZONE-MELTING OF MATERIAL; PRODUCTION OF A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; SINGLE CRYSTALS OR HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; AFTER-TREATMENT OF SINGLE CRYSTALS OR A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; APPARATUS THEREFOR
    • C30B33/00After-treatment of single crystals or homogeneous polycrystalline material with defined structure
    • CCHEMISTRY; METALLURGY
    • C30CRYSTAL GROWTH
    • C30BSINGLE-CRYSTAL GROWTH; UNIDIRECTIONAL SOLIDIFICATION OF EUTECTIC MATERIAL OR UNIDIRECTIONAL DEMIXING OF EUTECTOID MATERIAL; REFINING BY ZONE-MELTING OF MATERIAL; PRODUCTION OF A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; SINGLE CRYSTALS OR HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; AFTER-TREATMENT OF SINGLE CRYSTALS OR A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; APPARATUS THEREFOR
    • C30B7/00Single-crystal growth from solutions using solvents which are liquid at normal temperature, e.g. aqueous solutions
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13Crystalline forms, e.g. polymorphs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Metallurgy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Glass Compositions (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
PT168032480T 2015-05-29 2016-05-27 Processo para a produção de forma cristalina de enzalutamida PT3305770T (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2015109805 2015-05-29

Publications (1)

Publication Number Publication Date
PT3305770T true PT3305770T (pt) 2023-04-26

Family

ID=57442345

Family Applications (1)

Application Number Title Priority Date Filing Date
PT168032480T PT3305770T (pt) 2015-05-29 2016-05-27 Processo para a produção de forma cristalina de enzalutamida

Country Status (11)

Country Link
US (1) US10118899B2 (pt)
EP (1) EP3305770B1 (pt)
JP (1) JP6753396B2 (pt)
KR (1) KR102666017B1 (pt)
CN (1) CN107635969B (pt)
CA (1) CA2987563C (pt)
ES (1) ES2942618T3 (pt)
MX (1) MX385084B (pt)
PL (1) PL3305770T3 (pt)
PT (1) PT3305770T (pt)
WO (1) WO2016194813A1 (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3990435A1 (en) * 2019-06-27 2022-05-04 Synthon B.V. Process for preparation of enzalutamide
ES3055123T3 (en) 2019-10-03 2026-02-10 Synthon Bv Pharmaceutical composition comprising enzalutamide
CN111217757B (zh) * 2020-01-06 2021-03-19 武汉大学 一种恩杂鲁胺化合物及其药物组合物制剂
CN111303042A (zh) * 2020-03-25 2020-06-19 北京赛思源生物医药技术有限公司 一种恩杂鲁胺的新晶型
CN114591246A (zh) * 2022-03-25 2022-06-07 重庆华邦制药有限公司 一种恩扎卢胺的纯化方法
CN115536591B (zh) * 2022-09-27 2024-06-25 爱斯特(成都)生物制药股份有限公司 一种连续流制备恩扎卢胺的方法
WO2025125565A1 (en) 2023-12-13 2025-06-19 Krka, D.D., Novo Mesto Tablet comprising enzalutamide

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI1893196T2 (sl) 2005-05-13 2015-10-30 The Regents Of The University Of California Diarilhidantoinska spojina
MX2012009782A (es) 2010-02-24 2012-11-29 Medivation Prostate Therapeutics Inc Procesos para la sintesis de diariltiohidantoina y compuestos de diarilhidantoina.
CN103068940A (zh) * 2010-06-14 2013-04-24 索尔维特殊聚合物意大利有限公司 Pvdf涂料组合物
KR20150053963A (ko) 2012-09-11 2015-05-19 닥터 레디스 레보러터리즈 리미티드 엔잘루타마이드 다형태 및 그의 제조
CN106543085A (zh) 2013-10-14 2017-03-29 杭州普晒医药科技有限公司 恩杂鲁胺的固态形式及其制备方法和用途
US9611225B2 (en) 2014-01-27 2017-04-04 Cadila Healthcare Limited Process for preparation of androgen receptor antagonist
WO2016005875A1 (en) * 2014-07-11 2016-01-14 Shilpa Medicare Limited An improved process for the preparation of enzalutamide
CN104610158A (zh) 2015-02-03 2015-05-13 江苏慧博生物科技有限公司 一种恩杂鲁胺的精制方法
ITUB20151204A1 (it) 2015-05-28 2016-11-28 Olon Spa Procedimento per la preparazione di enzalutamide

Also Published As

Publication number Publication date
WO2016194813A1 (ja) 2016-12-08
EP3305770A4 (en) 2018-12-12
JP6753396B2 (ja) 2020-09-09
CN107635969A (zh) 2018-01-26
PL3305770T3 (pl) 2023-06-26
EP3305770A1 (en) 2018-04-11
EP3305770B1 (en) 2023-03-29
MX2017014958A (es) 2018-07-06
CA2987563A1 (en) 2016-12-08
CA2987563C (en) 2024-04-09
JPWO2016194813A1 (ja) 2018-06-07
KR102666017B1 (ko) 2024-05-16
CN107635969B (zh) 2021-08-17
ES2942618T3 (es) 2023-06-05
HK1251218A1 (en) 2019-01-25
KR20180014015A (ko) 2018-02-07
US10118899B2 (en) 2018-11-06
US20180148417A1 (en) 2018-05-31
MX385084B (es) 2025-03-14

Similar Documents

Publication Publication Date Title
IL289910B1 (en) A method for preparing allulose crystals
ZA201706213B (en) Process for producing stabilized polyacrylamides
ZA201708142B (en) Process for preparing 4-amino-pyridazines
SG11201701945RA (en) Process for making cyclohexanone
SG11201700443WA (en) Process for making cyclohexanone
PL3227023T3 (pl) Sposób wytwarzania kropel
SG11201701429SA (en) Process for making cyclohexanone
PL3305770T3 (pl) Sposób wytwarzania postaci krystalicznej enzalutamidu
PT3129356T (pt) Processo para produção de enzalutamida
SG11201701326YA (en) Method for producing oligosilane
IL252173A0 (en) Methods for the production of methyl dichlorophosphane
IL258148B (en) Methods for producing flumetamol
IL253877B (en) Process for the preparation of 3-chloro-2-vinylphenylsulfonates
PL3182981T3 (pl) Sposób wytwarzania izomaltooligosacharydów
ZA201801650B (en) Process for producing novel 4-benzoazonine derivatives
HUE049908T2 (hu) Eljárás L-metionin elõállítására
HUE049907T2 (hu) Eljárás L-metionin elõállítására
PL3299394T3 (pl) Sposób wytwarzania zmodyfikowanych ksylopolisacharydów
SG11201701480VA (en) Process for producing silicon single crystal
PL3006400T3 (pl) Sposób wytwarzania amoniaku
IL255093A0 (en) A method for the production of levoglucosenon
IL249283A0 (en) Process for the preparation of 3-chloro-2-vinylphenol
KZ31594B (ru) Способ производствашоколада
PL3105029T3 (pl) Sposób wytwarzania części
ZA201803631B (en) Improved process for making crotonylaminopyridines